Monkeypox is unlikely to become a global pandemic like COVID-19, but vaccine manufacturers are expanding their programs, just in case. Currently, there...
Bavarian Nordic announced Thursday that the upcoming Phase III trial for ABNCoV2, the Denmark-based biotech company's COVID-19 booster candidate, has been...
Galectin Therapeutics (NASDAQ: GALT), Galecto Biotech (NASDAQ: GLTO), and BioXyTran Inc. (OTCMKTS: BIXT)—these three companies all currently have market...
COVID-19 vaccines have had a huge beneficial impact on patient health. One study found that between December 2020 and June 2021, COVID-19 vaccines saved...
Although a handful of companies have dominated the COVID-19 vaccine market in the U.S. and Europe — Pfizer-BioNTech, Moderna, Johnson & Johnson,...
HAMILTON, June 10, 2022–McMaster University scientists who compared respiratory vaccine-delivery systems have confirmed that inhaled aerosol vaccines...
Which penny stocks are you watching right now? The post Hot Penny Stocks to Buy in Mid-June 2022? 3 to Watch appeared first on Penny Stocks...
Bioregnum Opinion Column by John Carroll Back at the beginning of the year during JP Morgan, I came up with my usual set of projections for...
Insilico Medicine has raised $60 million in fourth-round financing that will help to fund the advancement of more The post AI specialist Insilico raises...
Integrated Project Services describes how Inceptioneering, an early-stage planning process, can ease the shift from R&D to manufacturing. The post...
Rice University scientists developed molecular machines that are powered by visible light to kill infectious bacteria by drilling through their membranes....
GSK is counting on Affinivax to help it compete better with Pfizer’s blockbuster pneumococcal vaccine franchise, marketed as Prevnar®, and shore up...
GlaxoSmithKline has agreed a $3.3 billion takeover of US biotech Affinivax, buying a pneumococcal vaccine candidate that is The post GSK bolsters vaccines...
This is the second in a two-part series examining how pharma can embrace the DEI agenda to create The post Can technology help diversify clinical trials?...
In the diverse world we live in, the products we produce, the services we create and the places The post Why are clinical trials struggling with...
Health experts maintain that the current monkeypox situation is a stark contrast to Covid. Even so, a handful of biotechs have sprung to action, including...
NEW YORK, May 24, 2022 — Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $577 million to...
Enzolytics Inc (OTCMKTS: ENZC) is making a powerful move up the charts in recent days since reversing off $0.06 support levels, the second time it has...
With rare exceptions, each of the trillions of cells in our bodies carries an exact duplicate of the human genome, which contains between 20,000 and 25,000...
BioNTech continues to build on the success of the company's mRNA COVID-19 vaccine co-developed with Pfizer, rapidly expanding its investigational pipeline...
Johnson & Johnson has halved the size of its collaboration with Bavarian Nordic on vaccine development, jettisoning its The post J&J ducks out...
A collaboration between Gilead Sciences and Dragonfly Therapeutics was announced Monday, with an end goal of bringing Dragonfly's DF7001 natural...
Bill Haney’s Dragonfly Therapeutics is making the vault between biotech startup and the next big level: adding clinical-stage compounds to its own fledgling...
How might one gauge the contributions of selected geographical regions to cancer immunotherapy? Initially, one might assess cancer incidence and prevalence...
By Sungho Han, PhD, and Allan I. Levey, MD, PhD When science changes, it often takes a long time for nonscientists to catch up. The prevailing...
Humanized in vivo and in vitro systems are becoming more clinically relevant and facilitating better decisions earlier in drug development. The post Animal...
Plexium Inc. and AbbVie Inc. entered into an exclusive strategic collaboration to develop and commercialize novel Targeted Protein Degradation (TPD) therapeutics...
GSK’s strong Q1 driven by COVID-19, returning demand for shingles vaccine Published: Apr 27, 2022 By Mark Terry BioSpace GlaxoSmithKline exceeded expectations...
Enzolytics Inc (OTCMKTS: ENZC) is making an explosive move up the charts after the Company announced a progress update and more on its future plans. The...